RSS Newsfeeds

See all RSS Newsfeeds

Global Regions

Global Regions ( XML Feed )
United States ( XML Feed )

Sep 23, 2015 7:12 AM ET

Archived: Curazene, LLC: A biotechnology company seeking to take advantage of an orphan $4.5 billion US antibiotic market with a groundbreaking Antibiotic

iCrowdNewswire - Sep 23, 2015

Curazene, LLC

CZE-SR is a Texas LLC formed in November 2011 to sell its premier product Staph-Relief™ a topical Broad-spectrum OTC antibiotic that is safer and more effective in killing bacteria than the current antibiotics due to bacterial resistance. The CDC reported more than 1.7 million infections, 99,000 deaths in the US. Target market those with weakened immune systems, children, adults, athletes, those that live/work in close quarters and the Military.

Contact Information:

Ronald Lockard
Dominic Brown

View Related News >